RapidAI

RapidAI (formerly iSchemaView) is a US healthcare AI company founded in 2011 and headquartered in San Mateo, California, building on stroke-imaging algorithms originally developed at Stanford University in 2008. It addresses delays in interpreting emergency neuro and cardiovascular imaging that slow time-critical treatment decisions.

The platform connects CT and MRI scanners to AI modules that flag large-vessel occlusion, hemorrhage, aneurysm, and aortic or pulmonary-embolism findings, then push alerts to a mobile app so care teams can coordinate. Navigator Pro adds worklist prioritization for radiologists, while a life sciences module helps identify eligible patients for clinical trials. Customers include more than 2,500 hospitals in 100+ countries, among them Mayo Clinic and Stanford Healthcare.

1. Neurovascular AI: detects large-vessel occlusion, hemorrhage and aneurysm from CT/MRI in minutes.

2. Cardiac & vascular modules: flags aortic disease and pulmonary embolism on chest imaging.

3. Navigator Pro: prioritizes radiologist worklists by AI-flagged urgency.

4. Mobile alerts: pushes real-time notifications to stroke and cardiac care teams.

5. Life Sciences: identifies trial-eligible patients from imaging data for pharma sponsors.

6. Global deployment: integrates with PACS across 2,500+ hospitals in 100+ countries.